Salarius Pharmaceuticals, Inc.
SLRX
$0.8883
-$0.0105-1.17%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -58.88% | -58.74% | -56.68% | -71.64% | -52.84% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -51.76% | -46.52% | -27.53% | -15.34% | -14.82% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -52.28% | -54.18% | -54.08% | -70.61% | -51.41% |
|
|||||
Total Current Assets | -52.28% | -54.18% | -54.08% | -70.61% | -51.41% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -35.77% | -47.09% | -54.60% | -59.70% | -53.52% |
Total Assets | -52.10% | -54.10% | -54.08% | -70.52% | -51.43% |
|
|||||
Total Accounts Payable | 105.98% | 55.42% | -84.77% | -71.88% | -79.66% |
Total Accrued Expenses | 72.23% | -13.35% | -43.08% | -60.47% | -59.07% |
Short-term Debt | -4.02% | -23.38% | -28.38% | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 84.55% | 16.33% | -59.72% | -67.64% | -72.55% |
|
|||||
Total Current Liabilities | 84.55% | 16.33% | -59.72% | -67.64% | -72.55% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -4.02% | -23.38% | -28.38% | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 84.55% | 16.33% | -59.72% | -67.64% | -72.55% |
|
|||||
Common Stock & APIC | 2.43% | 2.21% | 2.25% | 0.52% | 9.38% |
Retained Earnings | -7.14% | -7.30% | -6.62% | -8.85% | -12.90% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -98.30% | -71.41% | -51.93% | -71.77% | -34.35% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -98.30% | -71.41% | -51.93% | -71.77% | -34.35% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -98.30% | -71.41% | -51.93% | -71.77% | -34.35% |
|